The complement system in neurodegenerative diseases.
Jacqui Nimmo1, Robert A J Byrne1, Nikoleta Daskoulidou1
1UK Dementia Research Institute Cardiff, Cardiff University, Cardiff CF24 4HQ, U.K.
Clinical Science (London, England : 1979)
|March 20, 2024
Summary
The complement system drives inflammation in neurological diseases like Alzheimer's, Parkinson's, schizophrenia, and multiple sclerosis. Targeting complement may offer new therapies for these conditions.
Area of Science:
- Immunology
- Neuroscience
- Pathology
Background:
- The complement system is vital for innate immunity and clearing immune complexes.
- Proper regulation of complement-mediated inflammation is essential for its protective functions.
- Dysregulated complement activation contributes to pathological inflammation in various diseases, including neurological disorders.
Purpose of the Study:
- To review the evidence implicating the complement system in neurodegenerative diseases.
- To focus on Alzheimer's disease, Parkinson's disease, schizophrenia, and multiple sclerosis.
- To briefly discuss the therapeutic potential and challenges of anti-complement drugs.
Main Methods:
- Literature review of studies investigating complement's role in neurological diseases.
- Analysis of evidence linking complement activation to disease pathology.
- Discussion of potential anti-complement drug therapies.
Main Results:
- Growing evidence implicates the complement system in neuroinflammatory and neurodegenerative diseases.
- Complement plays a role in Alzheimer's, Parkinson's, schizophrenia, and multiple sclerosis.
- Neurodegeneration is a significant feature in these diverse neurological conditions.
Conclusions:
- The complement system is a key driver of pathology in a range of neurological diseases.
- Targeting the complement system presents potential therapeutic strategies for neurodegenerative diseases.
- Further research is needed to fully understand the therapeutic potential and pitfalls of anti-complement therapies.
Related Concept Videos
01:27Complement System
2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
01:23Role of Neurotransmitters in Memory
548
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
548
01:26Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
01:28Disorders of the Nervous Tissue
1.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.3K
00:49The Blood-brain Barrier
47.3K
Overview
47.3K